drugset / Trial / NCT02652429
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
NaSingle-groupOpen-labelTreatment
Summary
An Open-Label Long-Term Safety Study of Inhaled Nitric Oxide (iNO) for Pulmonary Arterial Hypertension (PAH)
Timeline
- Start
- 2016-03
- Primary completion
- 2023-04
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 75 ug/kg | Inhaled |